Thomas Woiwode Crispr Therapeutics Ag (CRSP) insider trading activity
Thomas Woiwode is Director of CRISPR Therapeutics AG. Currently has a direct ownership of 5,629 shares of CRSP, which is worth approximately $229,212. The most recent transaction as insider was on May 08, 2018, when has been sold 1,653 shares (Common Shares) at a price of $51.45 per share, resulting in proceeds of $85,047. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.63K
0%
3M change
0%
12M change
Total Value Held
$229,212
Thomas Woiwode Transaction History
Also insider at
TW
Thomas Woiwode
Director
Cambridge, MA